Recruiting IgA Nephropathy Studies in Aurora
A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy
The purpose of this study is to evaluate the long-term safety and tolerability, of open label iptacopan in primary IgA nephropathy participants who have completed either the CLNP023X2203 or CLNP023A23...
Efficacy and Safety of Extended TARPEYO® Treatment Beyond 9 Months in Adult Patients With Primary IgA Nephropathy
The goal of this clinical trial is to assess the efficacy and safety of extended TARPEYO® (delayed-release budesonide capsules) treatment in adult patients with primary IgA nephropathy who have comple...
About IgA Nephropathy Clinical Trials in Aurora
IgA nephropathy is the most common form of glomerulonephritis worldwide, caused by deposits of immunoglobulin A in the kidneys. It can lead to kidney inflammation and progressive kidney damage. Treatment includes blood pressure management, immunosuppression, and newer targeted therapies.
There are currently 2 iga nephropathy clinical trials recruiting participants in Aurora, COLORADO. These studies are seeking a combined 600 participants. Research is being sponsored by Novartis Pharmaceuticals, Calliditas Therapeutics AB. Clinical trial participation is free and participants receive study-related medical care at no cost.
IgA Nephropathy Clinical Trials in Aurora — FAQ
Are there iga nephropathy clinical trials in Aurora?
Yes, there are 2 iga nephropathy clinical trials currently recruiting in Aurora, COLORADO. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Aurora?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Aurora research site will contact you about next steps.
Are clinical trials in Aurora free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Aurora studies also compensate for your time and travel.
What iga nephropathy treatments are being tested?
The 2 active trials in Aurora are testing new therapies including novel drugs, biologics, and treatment approaches for iga nephropathy.
Data updated March 2, 2026 from ClinicalTrials.gov